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Abstract  
 
Background and Purpose: Older adults have the highest risks of stroke and the lowest 
physical activity (PA) levels. It is important to quantify how walking (the predominant form 
of PA in older age) is associated with stroke. 
Methods: 4252 men from a UK population-based cohort reported usual PA (regular walking, 
cycling, recreational activity and sport) in 1998-2000.  Nurses took fasting blood samples and 
made anthropometric measurements. 
Results: Among 3435 ambulatory men free from CVD and heart failure in 1998-2000, 195 
first strokes occurred during 11 years follow-up.  Men walked a median of 7 (IQR 3-12) 
hours/week; walking more hours was associated with lower heart rate, D-dimer and higher 
FEV1.  Compared to men walking 0-3 hours/week, men walking  4-7, 8-14, 15-21 and >22 
hours, had age and region adjusted Hazard Ratios(HRs) (95%CIs) for stroke of 
0.89(0.60,1.31), 0.63(0.40,1.00), 0.68(0.35,1.32), and 0.36(0.14,0.91) respectively, p (trend)= 
0.006.  HRs were somewhat attenuated by adjustment for established and novel risk markers 
(inflammatory and hemostatic markers and cardiac function [NT-proBNP]) and walking 
pace, but linear trends remained.  There was little evidence for a dose response relationship 
between walking pace and stroke; comparing average pace or faster to a baseline of slow 
pace, the HR for stroke was 0.65 (95%CI 0.44, 0.97), which was fully mediated by time spent 
walking. 
Conclusions: Time spent walking was associated with reduced risk of onset of stroke in dose 
response fashion, independent of walking pace.  Walking could form an important part of 
stroke prevention strategies in older people. 
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Introduction:  
 
Stroke is a major cause of disability and mortality at older ages, so preventive strategies are 
important
1
.  Physical activity (PA) in middle age is protective against stroke; a meta-analysis 
reported that high compared to low PA levels were associated with overall 19% lower risk of 
stroke, although previous findings are mixed, with some inverse, u-shape and even positive 
associations
2
.  Some studies suggest that PA may be more protective against stroke at older 
ages than in middle age
3, 4
.   Walking is a predominant form of PA in older adults
5
.  It is 
therefore important to understand whether and how walking is related to onset of stroke in 
older adult populations, which have high risks of stroke and low activity levels. 
 
Whilst slower walking speeds and spending less time walking are associated with elevated 
total cardiovascular disease (CVD) mortality risk
6
, few prospective studies of stroke examine 
the relative importance of pace compared to time spent walking or distance walked
7
. Some 
suggest that both faster walking pace and greater time spent walking
3, 7, 8
 or MET hours
9
 of 
walking are protective against stroke and others have examined only walking speed
10, 11
.  It is 
not clear what factors may mediate associations between walking and onset of stroke.  To our 
knowledge, existing prospective studies of walking and stroke risk have not systematically 
addressed the mediating roles of novel cardiovascular markers
2
, including C-Reactive Protein 
(CRP) a marker of inflammation, D-dimer a marker of coagulation and fibrinolysis and NT-
ProBNP a marker of cardiac dysfunction, each of which is strongly related to onset of 
stroke
12-14
 and also to PA level
15, 16
.  
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We therefore test the hypotheses that (i) walking (pace, time spent and distance), and (ii) total 
leisure time PA are protective against onset of stroke.  We investigate the role of CRP, D-
dimer and NT-ProBNP alongside traditional risk factors as intermediate pathways.  
 
Methods   
Study Population  
The British Regional Heart Study is a prospective cohort of 7735 men recruited from a single 
Primary care centre in each of 24 British towns in 1978-80 (age 40-59 years).  Men were 
followed up for stroke morbidity and all-cause mortality.  In 1998-2000 4252 participants 
(aged 60-79 years) attended for follow-up measurements (77% response rate)
17
.  811 with 
pre-existing MI, stroke or heart failure and 6 confined to a wheelchair were excluded to 
reduce potential for reverse causality, leaving 3435 men. 
 
Clinical data, ethical approval 
Men completed questionnaires and nurses measured height, weight, blood pressure and FEV1 
(forced expiratory volume in one second)
17
 and recorded an ECG
12
 (including resting heart 
rate) and Minnesota coding criteria were used to define atrial fibrillation (8.3.1 and 8.3.3) and 
definite and possible left ventricular hypertrophy (3.1 and 3.3).  Fasting venous blood 
samples were collected and analysed for total and HDL-cholesterol, triglycerides
18
 and 
vitamin C
19
. CRP was assayed by ultrasensitive nephelometry (Dade Behring). Plasma levels 
of D-dimer were measured with ELISA (Biopool AB), as was von Willebrand factor (vWF) 
antigen (DAKO).  NT-proBNP was measured using the Elecsys 2010 
electrochemiluminescence method (Roche diagnostics, Burgess Hill, United Kingdom)
13
.  All 
relevant local research ethics committees provided ethical approval and all men provided 
informed written consent to the investigation. 
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Assessment of physical activity 
In 1998-2000 men self-reported usual pattern of PA under the headings of regular daily 
walking or cycling, recreational activity, and sporting (vigorous) activity.  Men reported 
usual walking during an average week (i) duration: number of hours spent on all forms of 
walking, (ii) distance: number of miles walked in total (iii) pace: slow, steady average, fairly 
brisk and fast (at least 4 mph). Men reporting recreational and sporting activity were 
classified according to whether or not they participated in vigorous activities at least once a 
month.  Recreational activity including eg gardening, pleasure walking (hiking), and do-it-
yourself jobs.  Sporting activity included eg running, golf, swimming and tennis.  A PA score 
(validated in relation to heart rate and FEV1
16, 20
) was derived for each man on the basis of 
frequency and type (intensity) of each activity, scored based on intensity and energy demands 
using Minnesota intensity codes.  The score included duration of walking but not distance 
walked or walking pace.  Questionnaire data was available for 3357/3435 (98%) about 
walking pace, 2995/3435 (87%) for hours walked per week and 3231 (94%) for distance 
walked per week; men with missing data for pace, distance or time spent walking were 
dropped from relevant analyses. 
 
Case ascertainment and follow-up 
The outcome was first fatal or non-fatal stroke occurring following the 1998-2000 survey up 
to June 2010.  Fatal cases were ascertained through the National Health Services Central 
Registers (death certificates with ICD-9 codes 430-438 for stroke, indicating deaths with 
cerebrovascular disease as the underlying cause).  Non-fatal stroke events were those that 
produced a neurological deficit that was present for >24 hours; data about non-fatal events 
was obtained from two-yearly reviews of patient primary care notes (including all hospital 
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and clinic correspondence). Supplementary information from CT/MRI scans to confirm 
diagnoses was available in a subset of men.   
 
Statistical methods 
Means, medians or proportions of behavioural and demographic factors selected a priori 
were calculated according to usual walking (i) pace (ii) duration (iii) distance reported at 
Q20.  Linear regression analyses were used to test trends across the walking categories.  
Skewed variables were natural log-transformed.  Variables exhibiting significant diurnal 
variation were adjusted for time of measurement . Blood pressure (BP) and body mass index 
(BMI) were adjusted for intra-observer variation.  
 
Cox proportional hazards regression models were used to estimate associations between Q20 
walking measures and risk of stroke.  Survival times were censored at date of stroke, death 
from any cause, or end of follow-up period, whichever occurred first.  Date of entry into the 
study in 1999-2000 was used as the time origin.  The proportional hazards assumption was 
examined using time varying covariates, calculating interactions of predictor variables and a 
function of survival time and including them in the models.  Examination of time varying 
covariates indicated that proportionality assumptions were not violated.  The Hazard Ratios 
(HRs) for categories of walking in 1999-2000 were estimated and the overall association was 
tested with the continuous association between walking (i) time (ii) distance and (iii) pace 
and stroke risk, adjusted for gender, age (continuous variable) and region of residence. Time 
and duration of walking were adjusted for pace, and pace adjusted for time.  Models were 
also adjusted for participation in vigorous recreational or sporting activities.  Models were 
next adjusted for covariates associated with both stroke and walking; established risk factors 
(alcohol and tobacco use, social class [based on occupational group “manual” (skilled 
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manual, unskilled or partly skilled) or “non-manual” (professional, managerial, technical, 
skilled non-manual occupations)]), then biological risk factors (as continuous variables):  first 
BMI and then systolic blood pressure (SBP), total and HDL cholesterol (HDL-C) and 
triglycerides, next FEV1 was added,  finally, novel risk markers, CRP, D-dimer and NT-
ProBNP were added.  Interactions were tested using likelihood ratio tests (LRT).  Analyses 
were repeated excluding the first two years of follow-up.   
 
Results  
Analyses are based on 3357 ambulatory men (mean age 68.3 years) who were free from 
CHD, stroke and heart failure at entry.  Men walked a median of 7 hours per week 
(interquartile range 3-12 hours).  The correlation between categories of hours walked and 
walking pace was r=0.08 (p<0.001) and hours walked and walking distance was r=0.22 
(p<0.001).  Men who walked for more hours  per week were younger, more likely to be of 
manual social class, reported higher levels of usual PA, had faster walking pace and reported 
walking more miles per week than those who walked for fewer hours.  The men who walked 
for more hours had lower heart rate, D-dimer and higher FEV1 (Table 1). 
 
Men reported usual walking pace as slow (13%, n=425), steady average (64%, n=2143) and 
fairly brisk or fast (24%, n=789).  Men with faster compared to slower walking pace were 
more likely to be younger, non-manual social class, never smokers, light drinkers, had higher 
usual PA levels, walked for more hours per week and longer distances, and had lower 
prevalence of diabetes (Supplementary Table 1).  Faster walking pace showed graded 
associations with lower BMI, waist circumference, plasma vitamin C, HDL-cholesterol, 
triglycerides, systolic blood pressure, use of blood pressure lowering medications, heart rate, 
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and inflammatory markers CRP, vWF, D-dimer and NTpro-BNP.  Men with a faster walking 
pace had a higher mean FEV1.  
 
During a median 10.9 years follow-up, 195 first stroke events occurred among 2995 men, 
6.7(95%CI 5.8, 7.7) per 1000 person-years.  The HRs for stroke reduced with increasing 
usual PA level, but confidence intervals (CIs) were wide (Table 2) and linear trends not 
significant.  Focusing next on walking, we did not find evidence for an association between 
usual distance walked and stroke (Table 3), although the HR for men who walked the furthest 
distance (>=15 miles/week) was smallest, but CIs were wide.  However, a strong inverse 
dose-response association was observed between time spent walking and risk of stroke (Table 
4).  Compared with  men spending 0-3 hours/week walking, men who walked 4-7, 8-14, 15-
21 and >22 hours had age and region adjusted HRs of 0.89(0.60,1.31), 0.63(0.40,1.00), 
0.68(0.35,1.32), 0.36(0.14,0.91) respectively, p(linear trend)=0.006.  Adjustments for 
multiple established risk factors including MVPA level (Model 2), walking pace (Model 3) 
and FEV1 (Model 4), attenuated associations to a very small degree.  CRP, D-dimer and NT-
ProBNP each attenuated coefficients to a similar degree when adjusted separately (not 
presented) or together (Model 5), and the linear trend remained significant.  We did not 
observe evidence for an interaction between time spent walking and pace (LRT, p=0.1).  In 
sensitivity analyses excluding the first two years of follow-up time, the point estimates were 
similar with slightly wider CIs, but significant trends remained.  
The risk of stroke was reduced for average pace compared to slow pace HR 0.66(0.43,0.99) 
with no further reduction for “fairly brisk” HR 0.64(0.39,1.07), so the average and fairly 
brisk were combined and compared to slow pace.  The HR for stroke was significantly 
reduced in “average or brisk pace” compared to slow pace, 0.62(0.42, 0.92) for Model 2 
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(Table 5), but was fully mediated on adjustment for either walking distance; HR 0.67(0.44, 
1.02), or duration; HR 0.67(0.43, 1.04). 
 
Supplementary information on CT/MRI scans was available for 75/195 (39%) of cases; 64/75 
(85%) were ischemic and 11/75 (15%) were hemorrhagic strokes.  In sensitivity analyses of 
the 64 ischemic cases, the dose-response pattern of lower risk with more hours walked was 
observed (p[trend]=0.004), no associations were observed for the number of miles walked 
and the estimates for walking pace were  similar to the main analyses. 
 
Discussion  
Among community dwelling older men, we observed a weak non-significant inverse 
association between total leisure time PA and stroke, and a strong inverse dose-response 
association between time spent walking and risk of stroke, independent of walking pace, 
MVPA, established and novel risk factors.  Results suggest that the total volume of walking 
rather than the intensity is important for stroke prevention.  We investigated a range of 
plausible mechanisms to explain associations between walking and stroke, including lipids, 
hypertension, markers of inflammation and endothelial dysfunction, but none fully mediated 
the associations with time spent walking. 
 
Comparison with other studies  
Findings about total PA and risk of stroke are mixed; inverse, u-shape and even positive 
associations are reported
2
.  We found weak evidence for an inverse association between total 
leisure-time PA or vigorous activity with onset of stroke, fitting with other null findings for 
total leisure time activity in men
3, 8
. However a meta-analysis concluded that high levels of 
leisure time PA were associated with a 19% reduction in risk of stroke
2
; our estimates for 
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moderate and more intense activity are of similar magnitude, although our confidence 
intervals (CIs) were wide.  
There is little epidemiologic evidence about walking pace and duration about stroke, most 
focuses on CHD and total CVD
6
.  Our findings that time spent walking was associated with 
reduced risk of stroke fits with the few existing studies which include middle aged and older 
adults
3, 7-9
, Hence our finding that time spent walking but not total PA was associated with 
stroke fits with other data; this consistency strengthens our speculation that it is a true 
biological finding, although we acknowledge that it could be due to issues with measurement 
of other types of PA. We did not find consistent evidence that walking pace was related to 
stroke onset; time spent walking explained the raised risk in slow-paced walkers.  Nor did we 
find that distance walked protected against stroke, although distance may be harder to recall 
accurately than usual pace or time spent walking. A large volume of weekly walking could be 
a proxy for low levels of sedentary behavior. A recent study reported that sedentary behavior 
is associated with stroke independently of PA
21
, although we cannot test this in our dataset.   
 
Our study is novel in exploring mechanisms; we found that established stroke risk factors 
(including blood pressure and lipids) were weak mediators of the associations between time 
spent walking and stroke as were markers of inflammation(CRP), coagulation(D-dimer) and 
also cardiac injury(NT-proBNP).  It is possible that associations between walking volume 
and ischemic stroke may be mediated through mechanisms related to progression of 
atherosclerosis and clot rupture that also act in CHD, whereas effects on hemorrhagic stroke 
may act through blood-pressure related mechanisms, but we could not test this hypothesis.   
Strengths and limitations 
This study benefits from prospective data with high follow-up rates, multiple measures of 
walking habit, (pace, time spent walking and distance) and other types of self-reported 
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habitual PA, combined in a score; both PA score
16, 20
 and time spent walking are related to 
heart rate and FEV1.  It is possible that there is a small degree of overlap between the total PA 
score (which uses weekend pleasure walking plus other components) and the daily walking 
variable (designed to capture active transport), but given that walking is protective against 
stroke, but the total PA score is not, any overlap is unlikely to have biased the score. Future 
studies with objective PA measures may clarify the shape of the dose-response curve between activity 
volume and intensity (including sedentary behavior) and stroke risk better than self-report which may 
be subject to recall bias, yet self-reports are required for identifying activity types.   
Whilst we cannot entirely exclude residual confounding as an explanation for our findings, 
we adjusted for a wide range of important behavioural and social confounders including other 
dimensions of walking and other types of physical activities. To reduce the risk of reverse 
causality, we excluded men with pre-existing physician diagnosed CVD, or confined to a 
wheelchair, as these men have increased mortality risks and are likely limit their PA due to 
their health.  We also excluded the first two years of follow-up in sensitivity analyses.  Unlike 
other studies of walking pace and duration, we could investigate the mediating role of novel 
and established biological risk factors which may be on the causal pathway between walking 
and stroke risk.  We were able to distinguish between subtypes of stroke in a subset of cases, 
and, as reported elsewhere
12
 ischemic strokes were more common than haemorrhagic strokes 
(a small minority) in older adults.  In a sensitivity analysis of men with CT-confirmed 
ischemic stroke findings were similar to those for all participants.  Our study examines only 
men, so we cannot generalize results to older women, however the sample is socio-
economically representative of older men in the UK and has exceptionally high follow-up 
rates.  One meta-analysis found borderline evidence for gender differences
22
 and another 
reported that more vigorous PA may be required for protection against stroke in women than 
in men
2
, but this may be because population levels of PA are lower in women than in men.  
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In conclusion, time spent walking was associated with risk of stroke in a dose-response 
fashion independent of walking pace and moderate to vigorous PA, indicating that among 
older men, daily walking could beneficially reduce risk of stroke.  Therefore walking for 
more hours per week could form an important part of stroke-prevention strategies.  Future 
studies using objective measures of habitual walking will shed more light on this question. 
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Table 1 Characteristics of men according to time spent walking per week, (n=2995 men).   
 
1-3 
hours/week 
(n=803) 
4-7 
hours/week 
(n=921) 
8-14 
hours/week 
(n=785) 
15-21 
hours/week 
(n=270) 
>=22 
hours/ 
week 
(n=216) 
P (trend)
*
 
Age 68.21 68.56 68.53 67.99 66.63 0.005 
Social class % (n)      <0.001 
Manual 45.6(365) 45.3(416) 48.7(381) 54.3(146) 64.4(139)  
Alcohol % (n)        0.081 
>15 units/week 13.6(107) 17.0(153) 19.8(150) 16.2(43) 16.5(35)  
Tobacco  % (n)      0.411 
current smoker 13.0(104) 11.6(107) 13.4(105) 13.4(36) 17.1(37)  
Physical activity score      <0.001 
None 22.6(177) 4.2(38) 1.9(15) 1.5(4) 2.3(5)  
Occasional  33.2(260) 26.6(242) 12.8(99) 7.5(20) 10.7(23)  
Light 14.6(114) 24.2(220) 20.3(157) 19.5(52) 21.9(47)  
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Moderate 8.2(64) 12.8(116) 24.1(187) 21.7(58) 27.4(59)  
moderately vigorous 11.5(90) 18.9(172) 20.6(160) 22.5(60) 18.1(39)  
Vigorous 9.8(77) 13.3(121) 20.3(157) 27.3(73) 19.5(42)  
Walking pace      <0.001 
Slow  20.8(166) 8.7(80) 7.4(58) 6.3(17) 8.9(19)  
Steady average 57.1(456) 65.1(596) 68.5(535) 66.9(180) 69.6(149)  
Brisk/fast 22.1(176) 26.2(240) 24.1(188) 26.8(72) 21.5(46)  
Miles walked/week
§
 3.9 6.9 9.7  10.6  10.1 <0.001 
Prevalent diabetes 11.8(95) 11.3(104) 9(71) 7(19) 8.8(19) 0.091 
BMI (kg/m
2
)
†
 27.01 26.61 26.69 26.60 26.87 0.274 
Waist circumference (cm)
†
 97.62 96.25 96.39 95.94 96.78 0. 051 
Plasma vitamin C 
(µmol/L)
§
 
22.71 23.31 23.15 21.76 19.26 0.052 
Total Cholesterol 
(mMol/L) 
6.03 6.10 6.07 6.12 5.95 0.892 
HDL-Cholesterol 1.34 1.33 1.35 1.36 1.32 0.697 
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(mMol/L) 
Triglycerides (mMol/L)
‡§
 1.60 1.62 1.60 1.61 1.50 0.250 
Systolic blood pressure 
(mmHg)
†‡
 
150.07 150.51 149.88 147.82 149.38 0.297 
Diastolic blood pressure 
(mmHg)
†‡
 
85.49 86.16 85.69 85.40 85.09 0.558 
Blood pressure lowering 
medication %(n) 
28.2(224) 28.6(260) 26.2(203) 26.3(70) 24.9(52) 0.674 
FEV1, (L)
||
 2.21 2.30 2.29 2.31 2.30 0.016 
Heart Rate (beats/minute) 66.14 66.31 65.42 64.70 64.10 0.007 
Atrial fibrillation %(n) 2.5(20) 2.6(24) 2.9(23) 2.6(7) 1.9(4) 0.931 
Left ventricular 
hypertrophy %(n) 
7.7(62) 6.6(61) 6.6(52) 8.6(23) 7.4(16) 0.754 
C-reactive protein, 
(mg/L)
§
 
1.78 1.51 1.64 1.44 1.74 0.248 
Von Willebrand Factor 137. 136.98 137.56 134.58 132.27 0.129 
19 
 
 
 
 
 
 
* 
P(trend) tested with linear regression for continuous variables and chi squared for categorical variables 
†
adjusted for inter-observer variation 
‡
adjusted for time of day 
§
 geometric mean 
||
 adjusted for inter-observer variation and height squared. 
  
(IU/dL) 
D-dimer (ng/mL)
§
 81.75 76.85 79.92 74.17 69.39 0.016 
NT-ProBNP (pg/mL)
§
 85.66 82.52 91.00 79.78 77.62 0.538 
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Table 2 Association between (i) total physical activity with onset of stroke, up to June 2010. 
1. Total leisure 
time physical 
activity 
None Occasional Light Moderate 
Moderately 
vigorous & 
vigorous 
Total P (trend) 
Participants(n) 269 690 569 475 992 2995  
Person years 2279 6451 5570 4768 9938 29,001  
Stroke events 
rates/ 1000 (n) 
7.9(18) 8.1(52) 7.5(42) 5.7(27) 5.6 (56) 6.7(195)  
HR (95% CI)*        
Model 1 1.0 1.08(0.63,1.85) 0.99(0.57,1.71) 0.81(0.44,1.48) 0.79(0.46,1.34)  0.092 
Model 2 1.0 1.05(0.61,1.82) 0.93(0.53,1.63) 0.80(0.43,1.47) 0.77(0.45,1.34)  0.100 
*
From Cox regression models of physical activity level and all stroke 
Model 1 = age+ region;  
Model 2 = model 1+alcohol intake (none/occasional, 1-15 units/week, >15 units/week)+smoking history (never-smoker, ex-smoker, current 
smoker)+social class (non-manual, manual and armed forces) + total cholesterol+ HDLc + loge (triglycerides) + SBP+ taking blood pressure 
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lowering medication+ BMI 
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Table 3 Association between distance walked /week with onset of stroke, up to June 2010. 
2. Distance walked/week 
0-3 miles/ 
week 
4-7 miles/ 
week 
8-14 miles/ 
week 
>15  miles/ 
week 
Total P (trend) 
Participants(n)  697 805 787 526 2815  
Person years  6508 7868 7714 5264 27,354  
Stroke events 
rates/ 1000 (n) 
 7.4(48) 6.6(52) 7.8(60) 4.9(26) 6.8(186)  
HR (95% CI)*        
Model 1  1.0 0.92(0.62,1.37) 1.12(0.76,1.64) 0.73(0.45,1.19)  0.505 
Model 2  1.0 0.89(0.60,1.33) 1.08(0.73,1.59) 0.70(0.43,1.15)  0.403 
*
From Cox regression models of physical activity level and all stroke 
Model 1 = age+ region;  
Model 2 = model 1+alcohol intake (none/occasional, 1-15 units/week, >15 units/week)+smoking history (never-smoker, ex-smoker, current 
smoker)+social class (non-manual, manual and armed forces) + total cholesterol+ HDLc + loge (triglycerides) + SBP+ taking blood pressure 
lowering medication+ BMI 
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Table 4 Association between time spent walking /week with onset of stroke, up to June 2010. 
3. Time spent 
walking/week 
0-3 
hours 
4-7 hours 8-14 hours 15-21 hours >=22 hours Total P (trend) 
Participants (n) 633 747 612 210 183 2385  
Person years 6024 7341 6024 2095 1060 23,196  
Stroke events 
rate/1000 (n) 
8.0(48) 7.7(56) 5.5(33) 5.3(11) 2.7(5) 6.6(153)  
HR (95% CI)*       
Model 1 1.0 0.89(0.60,1.31) 0.63(0.40,1.00) 0.68(0.35,1.32) 0.36(0.14,0.91)  0.006 
Model 2 1.0 0.88(0.60,1.31) 0.65(0.41,1.02) 0.69(0.35,1.34) 0.34(0.13,0.87)  0.006 
Model 3 1.0 0.90(0.61,1.33) 0.66(0.42,1.04) 0.70(0.36,1.36) 0.35(0.14,0.88)  0.008 
Model 4 1.0 0.89(0.60,1.33) 0.66(0.42,1.04) 0.70(0.36,1.36) 0.35(0.14,0.88)  0.007 
Model 5 1.0 0.91(0.61,1.34) 0.66(0.42,1.04) 0.70(0.36,1.36) 0.35(0.14,0.89)  0.008 
*
From Cox regression models of physical activity level and all stroke 
Model 1 = age+ region;  
Model 2 = model 1+alcohol intake (none/occasional, 1-15 units/week, >15 units/week)+smoking history (never-smoker, ex-smoker, current 
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smoker)+social class (non-manual, manual and armed forces) + total cholesterol+ HDLc + loge (triglycerides) + SBP+ taking blood pressure 
lowering medication+ BMI 
Model 3= model 2+ walking pace  
Model 4= model 3+ FEV1 
Model 5= model 3+ loge (C-reactive protein) + loge (d-dimer) + loge (NT-ProBNP) 
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Table 5 Association between usual walking pace week with onset of stroke, up to June 2010. 
4. Walking pace Slow >=Steady average Total P (trend) 
Participants (n) 319 2464   2783  
Person years 2626 2441   27067  
Stroke events rate/ 1000 
(n) 
11.8(31) 6.1(150)   6.7(181)  
HR (95% CI)*       
Model 1  1.00 0.62(0.42,0.92)    0.017 
Model 2  1.00 0.66(0.44,1.00)    0.038 
Model 3  1.00 0.67(0.44,1.02)     0.063 
Model 4  1.00 0.67(0.43,1.04)    0.077 
*
From Cox regression models of physical activity level and all stroke 
Model 1 = age+ region;  
Model 2 = model 1+alcohol intake (none/occasional, 1-15 units/week, >15 units/week)+smoking history (never-smoker, ex-smoker, current 
smoker)+social class (non-manual, manual and armed forces) + total cholesterol+ HDLc + loge (triglycerides) + SBP+ taking blood pressure 
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lowering medication+ BMI 
Model 3= model 2 + waking distance 
Model 4= model 2 + walking time 
 
 
